iBio, Inc.
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
IBIO | US
Overview
Corporate Details
- ISIN(s):
- US4510332038
- LEI:
- Country:
- United States of America
- Address:
- 600 MADISON AVENUE, SUITE 1601, NEW YORK
- Website:
- https://ibioinc.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
iBio, Inc. is a preclinical-stage biotechnology company that leverages its patented, AI-powered discovery platform to develop next-generation biopharmaceuticals. The company specializes in creating precision antibody therapeutics targeting complex cardiometabolic diseases and obesity. By integrating advanced computational biology, machine learning, and its epitope-steered discovery engine, iBio aims to accelerate the development of novel medicines for difficult-to-drug targets. The company advances its proprietary pipeline of therapeutic candidates while also engaging in strategic collaborations to fuel breakthroughs in drug discovery.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all iBio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for iBio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for iBio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
